Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Research

Remedy: Back in the game

By Atte RiikolaAnalyst
Remedy Entertainment
Download report (PDF)

The investor sentiment around Remedy has recently soured, where we believe the key factors are the write-down of Vanguard’s development expenditure and the postponement of the financial statements based on publishing contract negotiations. In addition, uncertainty about Alan Wake 2’s commercial success causes uncertainty around the stock. We believe that the content of the publishing contract and the sales figures of AW2 will be clarified in connection with the financial statements (3/20) at the latest, and with the decreased valuation we feel Remedy's long-term potential looks interesting again.

Login required

This content is only available for logged in users

Create account

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more on company page

Key Estimate Figures12.02.2024

202223e24e
Revenue43.633.967.2
growth-%-2.5 %-22.2 %98.3 %
EBIT (adj.)-0.6-28.79.9
EBIT-% (adj.)-1.3 %-84.6 %14.8 %
EPS (adj.)-0.13-1.710.59
Dividend0.100.100.10
Dividend %0.5 %0.6 %0.6 %
P/E (adj.)neg.neg.27.9
EV/EBITDA126.5neg.12.9

Forum discussions

It seems quite clear that both characters are in the game and are related to the story. The open question is whether both are playable. It’s...
2 hours ago
by Jarnis
2
Unsurprisingly, some parts of the Internet are of the opinion that changing the main character is a mistake and the game is now ruined. From...
3 hours ago
by Flouride
4
Let’s make a separate poll to see if it works this way Control Resonant track sales by the end of 2026 Under 0.5M 0.5M - 0.99M 1M - 1.49M 1....
3 hours ago
by Henkka
1
Very much along the same lines. This increasing probability of momentum is further strengthened when examining the trend in the number of Nordnet...
4 hours ago
by Henkka
6
Control: It’s now just over a day since the first trailer for Control: Resonant was released. I took a closer look at the game’s reception, ...
5 hours ago
by Akee
27
Hello to the thread. I’ve also been a long-time Remedy bear, but I took a big position on this last Friday for under 16e. Not investment advice...
6 hours ago
by Umpi
10
Great trailer and the hype started nicely. Hopefully, the Remedyverse is hammered with a customizable sledgehammer into the black hole at the...
18 hours ago
by T4K1_
5
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.